230 related articles for article (PubMed ID: 29851436)
1. Integrated delivery of antiretroviral treatment and pre-exposure prophylaxis to HIV-1 serodiscordant couples in East Africa: a qualitative evaluation study in Uganda.
Ware NC; Pisarski EE; Nakku-Joloba E; Wyatt MA; Muwonge TR; Turyameeba B; Asiimwe SB; Heffron RA; Baeten JM; Celum CL; Katabira ET
J Int AIDS Soc; 2018 May; 21(5):e25113. PubMed ID: 29851436
[TBL] [Abstract][Full Text] [Related]
2. Beyond HIV prevention: everyday life priorities and demand for PrEP among Ugandan HIV serodiscordant couples.
Nakku-Joloba E; Pisarski EE; Wyatt MA; Muwonge TR; Asiimwe S; Celum CL; Baeten JM; Katabira ET; Ware NC
J Int AIDS Soc; 2019 Jan; 22(1):e25225. PubMed ID: 30657642
[TBL] [Abstract][Full Text] [Related]
3. I Knew I Would Be Safer. Experiences of Kenyan HIV Serodiscordant Couples Soon After Pre-Exposure Prophylaxis (PrEP) Initiation.
Ngure K; Heffron R; Curran K; Vusha S; Ngutu M; Mugo N; Celum C; Baeten JM
AIDS Patient Care STDS; 2016 Feb; 30(2):78-83. PubMed ID: 26836236
[TBL] [Abstract][Full Text] [Related]
4. Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda.
Baeten JM; Heffron R; Kidoguchi L; Mugo NR; Katabira E; Bukusi EA; Asiimwe S; Haberer JE; Morton J; Ngure K; Bulya N; Odoyo J; Tindimwebwa E; Hendrix C; Marzinke MA; Ware NC; Wyatt MA; Morrison S; Haugen H; Mujugira A; Donnell D; Celum C;
PLoS Med; 2016 Aug; 13(8):e1002099. PubMed ID: 27552090
[TBL] [Abstract][Full Text] [Related]
5. PrEP Discontinuation and Prevention-Effective Adherence: Experiences of PrEP Users in Ugandan HIV Serodiscordant Couples.
Gilbert HN; Wyatt MA; Pisarski EE; Muwonge TR; Heffron R; Katabira ET; Celum CL; Baeten JM; Haberer JE; Ware NC
J Acquir Immune Defic Syndr; 2019 Nov; 82(3):265-274. PubMed ID: 31609925
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of pre-exposure prophylaxis targeted to high-risk serodiscordant couples as a bridge to sustained ART use in Kampala, Uganda.
Ying R; Sharma M; Heffron R; Celum CL; Baeten JM; Katabira E; Bulya N; Barnabas RV
J Int AIDS Soc; 2015; 18(4 Suppl 3):20013. PubMed ID: 26198348
[TBL] [Abstract][Full Text] [Related]
7. Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.
Morton JF; Celum C; Njoroge J; Nakyanzi A; Wakhungu I; Tindimwebwa E; Ongachi S; Sedah E; Okwero E; Ngure K; Odoyo J; Bulya N; Haberer JE; Baeten JM; Heffron R;
J Acquir Immune Defic Syndr; 2017 Jan; 74 Suppl 1(Suppl 1):S15-S22. PubMed ID: 27930607
[TBL] [Abstract][Full Text] [Related]
8. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.
Patel RC; Stanford-Moore G; Odoyo J; Pyra M; Wakhungu I; Anand K; Bukusi EA; Baeten JM; Brown JM
J Int AIDS Soc; 2016; 19(1):21134. PubMed ID: 27964776
[TBL] [Abstract][Full Text] [Related]
9. Delivering safer conception services to HIV serodiscordant couples in Kenya: perspectives from healthcare providers and HIV serodiscordant couples.
Ngure K; Kimemia G; Dew K; Njuguna N; Mugo N; Celum C; Baeten JM; Heffron R
J Int AIDS Soc; 2017 Mar; 20(Suppl 1):21309. PubMed ID: 28361508
[TBL] [Abstract][Full Text] [Related]
10. "We are in this together:" dyadic-level influence and decision-making among HIV serodiscordant couples in Tanzania receiving access to PrEP.
Fonner VA; Ntogwisangu J; Hamidu I; Joseph J; Fields J; Evans E; Kilewo J; Bailey C; Goldsamt L; Fisher CB; O'Reilly KR; Ruta T; Mbwambo J; Sweat MD
BMC Public Health; 2021 Apr; 21(1):720. PubMed ID: 33853559
[TBL] [Abstract][Full Text] [Related]
11. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
Haberer JE; Kidoguchi L; Heffron R; Mugo N; Bukusi E; Katabira E; Asiimwe S; Thomas KK; Celum C; Baeten JM
J Int AIDS Soc; 2017 Jul; 20(1):21842. PubMed ID: 28741331
[TBL] [Abstract][Full Text] [Related]
12. Experiences Using Pre-Exposure Prophylaxis for Safer Conception Among HIV Serodiscordant Heterosexual Couples in the United States.
Bazzi AR; Leech AA; Biancarelli DL; Sullivan M; Drainoni ML
AIDS Patient Care STDS; 2017 Aug; 31(8):348-355. PubMed ID: 28719229
[TBL] [Abstract][Full Text] [Related]
13. Safer conception among HIV-1 serodiscordant couples in East Africa: understanding knowledge, attitudes, and experiences.
Hancuch K; Baeten J; Ngure K; Celum C; Mugo N; Tindimwebwa E; Heffron R;
AIDS Care; 2018 Aug; 30(8):973-981. PubMed ID: 29455572
[TBL] [Abstract][Full Text] [Related]
14. What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples.
Ware NC; Wyatt MA; Haberer JE; Baeten JM; Kintu A; Psaros C; Safren S; Tumwesigye E; Celum CL; Bangsberg DR
J Acquir Immune Defic Syndr; 2012 Apr; 59(5):463-8. PubMed ID: 22267018
[TBL] [Abstract][Full Text] [Related]
15. Adherence to recommendations for ART and targeted PrEP use among HIV serodiscordant couples in East Africa: the "PrEP as a bridge to ART" strategy.
Musinguzi N; Kidoguchi L; Mugo NR; Ngure K; Katabira E; Celum CL; Baeten JM; Heffron R; Haberer JE;
BMC Public Health; 2020 Oct; 20(1):1621. PubMed ID: 33115478
[TBL] [Abstract][Full Text] [Related]
16. Healthcare providers' understanding of HIV serodiscordance in South Africa and Uganda: implications for HIV prevention in sub-Saharan Africa.
Greener R; Milford C; Bajunirwe F; Mosery FN; Ng CK; Rifkin R; Kastner J; Pillay L; Kaida A; Bangsberg DR; Smit JA; Matthews LT
Afr J AIDS Res; 2018 Jul; 17(2):137-144. PubMed ID: 29745290
[TBL] [Abstract][Full Text] [Related]
17. Short Message Service (SMS) Surveys Assessing Pre-exposure Prophylaxis (PrEP) Adherence and Sexual Behavior are Highly Acceptable Among HIV-Uninfected Members of Serodiscordant Couples in East Africa: A Mixed Methods Study.
Muwonge TR; Ngure K; Katabira E; Mugo N; Kimemia G; Burns BFO; Musinguzi N; Bambia F; Baeten JM; Heffron R; Haberer JE;
AIDS Behav; 2019 May; 23(5):1267-1276. PubMed ID: 30406335
[TBL] [Abstract][Full Text] [Related]
18. Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study.
Hallett TB; Baeten JM; Heffron R; Barnabas R; de Bruyn G; Cremin Í; Delany S; Garnett GP; Gray G; Johnson L; McIntyre J; Rees H; Celum C
PLoS Med; 2011 Nov; 8(11):e1001123. PubMed ID: 22110407
[TBL] [Abstract][Full Text] [Related]
19. Provider perspectives on service delivery modifications to maintain access to HIV pre-exposure prophylaxis during the COVID-19 pandemic: qualitative results from a PrEP implementation project in Kenya.
Velloza J; Roche SD; Owidi EJ; Irungu EM; Dollah A; Kwach B; Thuo NB; Morton JF; Mugo N; Bukusi EA; O'Malley G; Ngure K; Baeten JM; Mugwanya KK;
J Int AIDS Soc; 2023 Feb; 26(2):e26055. PubMed ID: 36739603
[TBL] [Abstract][Full Text] [Related]
20. Fertility Intentions, Pregnancy, and Use of PrEP and ART for Safer Conception Among East African HIV Serodiscordant Couples.
Heffron R; Thomson K; Celum C; Haberer J; Ngure K; Mugo N; Bukusi E; Katabira E; Odoyo J; Bulya N; Asiimwe S; Tindimwebwa E; Baeten JM;
AIDS Behav; 2018 Jun; 22(6):1758-1765. PubMed ID: 28894986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
